Researching women's health is like "opening a can of worms" but is imperative for equality in sports and nutrition, says Mariko Hill, global innovations manager at Gencor.
An industry funded study concludes the branded palmitoylethanolamide (PEA) ingredient ‘Levagen+’ is safe and effective in reducing the incidence and symptoms associated with upper respiratory tract infections (URTIs).
Gencor’s branded PEA can now be found in the beauty category for its ability to aid in a healthy inflammatory response and protect from oxidative stress-induced damage.
Palmitoylethanolamide (PEA) reduces sensitivity to pain in the central and peripheral nervous systems and increases pain modulation, says a recent study from Austrian researchers.
Palmitoylethanolamide (PEA) has shown to inhibit the COVID-19 virus in both in-silico and in-vitro settings, and positive findings from a clinical trial are expected to be published in Q3, says functional ingredient firm Gencor.
Palmitoylethanolamide (PEA) is a safer and more pervasive therapeutic alternative to cannabidiol, say the authors of the Gencor Pacific-commissioned review, ‘Palmitoylethanolamide: A Potential Alternative to Cannabidiol.’
A wrinkled type of ‘super pea,’ containing higher levels of gut-friendly ‘resistant starch,’ may prove beneficial to those at risk of type 2 diabetes, due to its ability to control blood sugar levels, a study thinks.
A Palmitoylethanolamide (PEA) supplement matches the efficacy of ibuprofen for reducing pain severity and duration of headaches creating an exciting opportunity within the eSports category, says Gencor.
